The discovery that NNMT expression is dramatically elevated in adipose tissue of obese humans and animal models, and that NNMT inhibition or knockdown prevents diet-induced obesity and improves metabolic health, has catalyzed intense research interest in NNMT as a therapeutic target for obesity, metabolic syndrome, and related conditions
Property NAD+ (Nicotinamide Adenine Dinucleotide) MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) 5-Amino-1MQ (5-Amino-1-methylquinolinium) Molecular Formula CHNOP CHNOS CHN Molecular Weight 663.43 g/mol 2174.6 g/mol 159.21 g/mol PubChem CID 925 255386757 950107 CAS Number 53-84-9 1627580-64-6 42464-96-0 Synonyms -Nicotinamide adenine dinucleotide, DPN, Coenzyme I, Diphosphopyridine nucleotide Human MOTS-c, UNII-A5CV6JFB78, MOTS-c trifluoroacetate salt 5-amino-1-methylquinolinium, SCHEMBL6403148, CHEMBL4116828, ZMJBCEIHNOWCMC-UHFFFAOYSA-O, STL196667
Top Benefits: Drives average weight reductions of up to 20-26% when combined with healthy lifestyle habits Improves insulin response and glucose stability Boosts overall metabolic performance and energy balance Real Science
Injections are given intramuscularly and should only be administered by trained clinicians to ensure safety and effectiveness